Change of Registered Office

In brief · summary, not quotable

Coiled Therapeutics PLC has announced a change to its registered office, effective immediately, relocating to 167-169 Great Portland Street, 5th Floor, London W1W 5PF. This administrative update does not alter the company's focus as a clinical-stage precision oncology firm developing small molecule therapies for genetically defined cancers, including its lead program AO-252, a TACC3 inhibitor currently in Phase I trials.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your COIL notes

Coiled Therapeutics (AIM: COIL) (OTCQB: COTXF), the clinical-stage precision oncology company developing differentiated small molecule therapies for genetically defined cancers, announces that, with immediate effect, the registered office of the Company has changed to 167-169 Great Portland Street, 5th Floor, London W1W 5PF, United Kingdom.

About AO-252

For more information, please visit: www.coiledplc.com and follow us on LinkedIn.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.